There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Yield10 Bioscience Inc (NASDAQ:YTEN) and Anheuser-Busch Inbev Sa (NYSE:BUD) with bullish sentiments.
Yield10 Bioscience Inc (YTEN)
In a report released today, James Jang from Maxim Group reiterated a Buy rating on Yield10 Bioscience Inc, with a price target of $7. The company’s shares closed yesterday at $1.38, close to its 52-week low of $1.12.
Jang noted:
“Thursday, after Market close, YTEN reported 2Q18 results with revenue of $0.3 million, above our inline estimate of $0.1 million, with a loss per share of $(0.24), better than our estimate of a loss of $(0.30) per share. Field tests remain on schedule, with planting completed during 2Q18 and data expected in 4Q18. Recently announced research license agreement with the Broad Institute highlights our thesis that YTEN will continue to seek partnerships to accelerate its path toward commercialization. With the company on track in its field trials, we reiterate our Buy rating and $7 Price Target.”
According to TipRanks.com, Jang is a 4-star analyst with an average return of 18.9% and a 48.9% success rate. Jang covers the Services sector, focusing on stocks such as Dynagas LNG Partners LP, Nordic American Tanker, and Eagle Bulk Shipping.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Yield10 Bioscience Inc with a $7 average price target.
See today’s analyst top recommended stocks >>
Anheuser-Busch Inbev Sa (BUD)
Susquehanna analyst Pablo Zuanic reiterated a Buy rating on Anheuser-Busch Inbev Sa today and set a price target of $137. The company’s shares closed yesterday at $99.71.
Zuanic noted:
“We have increased conviction about the company’s organic global growth opportunity (better portfolio management, segmentation, and customization to levels of market maturity; greater focus on expanding the beer category; a mindset to apply the company’s rigor and discipline in garnering cost savings, to now with the same zeal also growing top line; new capabilities and organization, allowing for sharing of best practices). India will likely be the biggest contributors to global beer industry growth, BUD also sees Africa accounting for 20% of its global volume growth. Although partly an emerging markets play (72% of volumes), developed markets still account for close to 35-40% of BUD’s EBITDA. In that context, we think the US unit will benefit from the ideas successfully implemented in other developed markets (Australia, UK).”
According to TipRanks.com, Zuanic is a 4-star analyst with an average return of 6.7% and a 56.9% success rate. Zuanic covers the Consumer Goods sector, focusing on stocks such as Coca-Cola European Partners, Constellation Brands Inc, and Craft Brewers Alliance.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Anheuser-Busch Inbev Sa with a $118.67 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
